This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Arthur L. Reingold, MD

JAMA. 1986;255(2):242-243.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A little over five years ago, following the widespread dissemination of the results of epidemiologic studies linking menstrual toxic shock syndrome (TSS) to the use of tampons, many women switched to other forms of menstrual protection. As a result, the percentage of menstruating women who used tampons fell from 70% to 49%. In addition, the manufacturer of a single brand of tampons withdrew its product from the market after further studies demonstrated that users of that brand were at increased risk of developing menstrual TSS compared with users of other brands. In these studies, the relative risks or odds ratios (the extent to which users of a given product were at increased risk of developing TSS, compared with nonusers) were in the range of 8 to 30. Thus, tampon users in general were approximately 18 times as likely to develop menstrual TSS as nonusers,¹ and users of Rely brand . . . [Full Text PDF of this Article]

Author Affiliations
Centers for Disease Control Atlanta

Footnotes
Address editorial communications to the Editor, 535 N Dearborn St, Chicago, IL 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?